PROX1 was a significant marker of better prognosis in the subgroup of intestinal cancer type (p = 0.025; Fig 3A) whereas it did not show a prognostic significance among patients with diffuse cancer type (p = 0.290; Fig 3B). Here, PROX1 is linked to intestinal cancer.